Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
How viral proteins bind short linear motifs and intrinsically disordered domains
Uppsala University, Disciplinary Domain of Science and Technology, Chemistry, Department of Chemistry - BMC, Biochemistry.
Inst Canc Res, Div Canc Biol, London, England..
Uppsala University, Disciplinary Domain of Science and Technology, Chemistry, Department of Chemistry - BMC, Biochemistry.ORCID iD: 0000-0002-7081-3846
2022 (English)In: Essays in Biochemistry, ISSN 0071-1365, E-ISSN 1744-1358, Vol. 66, no 7, p. 935-944Article, review/survey (Refereed) Published
Abstract [en]

Viruses are the obligate intracellular parasites that exploit the host cellular machinery to repli-cate their genome. During the viral life cycle viruses manipulate the host cell through inter-actions with host proteins. Many of these protein-protein interactions are mediated through the recognition of host globular domains by short linear motifs (SLiMs), or longer intrinsically disordered domains (IDD), in the disordered regions of viral proteins. However, viruses also employ their own globular domains for binding to SLiMs and IDDs present in host proteins or virus proteins. In this review, we focus on the different strategies adopted by viruses to utilize proteins or protein domains for binding to the disordered regions of human or/and viral ligands. With a set of examples, we describe viral domains that bind human SLiMs. We also provide examples of viral proteins that bind to SLiMs, or IDDs, of viral proteins as a part of complex assembly and regulation of protein functions. The protein-protein interactions are often crucial for viral replication, and may thus offer possibilities for innovative inhibitor design.

Place, publisher, year, edition, pages
Portland Press, 2022. Vol. 66, no 7, p. 935-944
National Category
Biochemistry Molecular Biology
Identifiers
URN: urn:nbn:se:uu:diva-495632DOI: 10.1042/EBC20220047ISI: 000905318800010PubMedID: 36504386OAI: oai:DiVA.org:uu-495632DiVA, id: diva2:1733229
Available from: 2023-02-01 Created: 2023-02-01 Last updated: 2025-02-20Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textPubMed

Authority records

Madhu, PriyankaIvarsson, Ylva

Search in DiVA

By author/editor
Madhu, PriyankaIvarsson, Ylva
By organisation
Biochemistry
In the same journal
Essays in Biochemistry
BiochemistryMolecular Biology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 294 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf